Trend and area variation in amphetamine prescription usage among children and adolescents in Michigan

Social Science and Medicine

Volumn 60, Issue 3, 2005, Pages 617-626

  Lin, Swu Jane ^a   Crawford, Stephanie Y ^a   Lurvey, Patricia L ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Amphetamine; Area variation; Children and adolescents; Prescribing rate; Spatial analysis; USA

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; METHAMPHETAMINE;

DRUG PRESCRIBING;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; AWARENESS; CHILD; DATA ANALYSIS; DRUG USE; HEALTH CARE POLICY; HUMAN; MEDICAL RESEARCH; OUTPATIENT; POPULATION RESEARCH; PRESCRIPTION; STATISTICAL ANALYSIS; UNITED STATES;

ADOLESCENT; AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DRUG UTILIZATION; HEALTH SERVICES RESEARCH; HUMANS; MICHIGAN; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 8644234076     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2004.06.002     Document Type: Article

References (47)

1. Abraham J., Sheppard J. The therapeutic nightmare. the battle over the world's most controversial sleeping pill:1999;Earthscan Publications Ltd, London
2. ADHD focuses. (2003, December 3). ADHD focuses on adults. USA Today, p. 01d.
3. American Academy of Pediatrics. (2000). Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics, 105, 1158-1170.
4. Anonymous. (1997). Child and learning disability psychopharmacology. Journal of Psychopharmacology, 11(4), 291-294.
5. Anselin L. Local indicators of spatial association - LISA. Geographical Analysis. 27:1995;93-116
6. Anselin L. The future of spatial analysis in the social sciences. Geographic Information Sciences. 5:1999;67-76
7. Arnst, C. (2003, October 27). Attention deficit: not just kid stuff. Business Week, 84-86.
8. Bauchner H. ADHD. A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder Archives of Disease in Childhood. 83:2000;63
9. Cliff A., Ord J. Spatial autocorrelation. 1973;Pion, London
10. Cox E.R., Motheral B.R., Henderson R.R., Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old. results from a commercially insured US sample Pediatrics. 111:2003;237-243
11. Diehr P., Cain K., Connell F., Volinn E. What is too much variation? The null hypothesis in small-area analysis. Health Services Research. 24:1990;741-771
12. Diehr P., Cain K.C., Kreuter W., Rosenkranz S. Can small-area analysis detect variation in surgery rates? The power of small-area variation analysis. Medical Care. 30:1992;484-502
13. Drug Enforcement Administration, DEA. (2000). Committee on Education and the workforce: Subcommittee on early childhood, youth and families. DEA congressional testimony, May 16. Retrieved June 10, 2003, from http://www.usdoj.gov/dea/pubs/cngrtest/ct051600.htm
14. Drug Enforcement Administration, DEA. (2001). Stimulant abuse by school age children: A guide for school officials. Retrieved June 10, 2003, from http://www.deadiversion.usdoj.gov/pubs/brochures/stimulant/stimulant_abuse.htm
15. Dubois R.W., Batchlor E., Wade S. Geographic variation in the use of medications. Is uniformity good news or bad? Health Affairs. 21(1):2002;240-250
16. Elia J., Ambrosini P.J., Rapoport J.L. Treatment of attention-deficit- hyperactivity disorder. New England Journal of Medicine. 340:1999;780-788
17. Faraone S.V., Biederman J., Roe C. Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder. A meta-analysis Journal of Clinical Psychopharmacology. 22:2002;468-473
18. Fotheringham A.S., Brunsdon C., Charlton M. Quantitative geography. 2000;Sage Publications, London
19. Halasz G. A symposium on attention deficit hyperactivity disorder (ADHD) - an ethical perspective. Australian and New Zealand Journal of Psychiatry. 36(4):2002;472-475
20. Healy D. The creation of psychopharmacology. 2002;Harvard University Press, Cambridge, MA
21. Jensen P.S. Commentary: The NIM ADHD consensus statement. Win, lose, or draw? Journal of the American Academy of Child and Adolescent Psychiatry. 39(2):2000;194-197
22. Klorman R., Brumaghim J.T., Fitzpatrick P.A., Borgstedt A.D. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 29:1990;702-709
23. Kratochvil C.J., Heiligenstein J.H., Dittmann R., Spencer T.J., Biederman J., Wernicke J., et al. Atomoxetine and methylphenidate treatment in children with ADHD. A prospective, randomized, open-label trial Journal of the American Academy of Child and Adolescent Psychiatry. 41:2002;776-784
24. Krieger N. Epidemiology and the web of causation. Has anyone seen the spider? Social Science & Medicine. 39:1994;887-903
25. Kupfer D.J., Baltimore R.S., Berry D.A., Breslau N., Ellinwood E.H., et al. National Institutes of Health Consensus Development Conference Statement. Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) Journal of the American Academy of Child and Adolescent Psychiatry. 39(2):2000;182-193
26. Lee J., Wong D.W. Statistical analysis with ArcVIEW GIS. 2001;Wiley, New York
27. Leo J. Attention deficit disorder. Good science or good marketing Skeptic. 8(1):2000;63-69
28. Martin E. Flexible bodies, tracking immunity in American culture from the days of polio to the age of AIDS. 1994;Beacon Press, Boston, MA
29. Michigan Department of Consumer & Industry Services. (1997). Office of Health Services and Michigan Controlled Substances Advisory Commission. Michigan official prescription program evaluation report. Lansing, MI: Author.
30. Odland J. Spatial autocorrelation. 1988;Sage, Newbury Park, CA
31. Openshaw, S., & Taylor, P. (1979). A million or so correlation coefficients: three experiments on the modifiable areal unit problem. In N. Wrigley (Ed.), Statistical applications in the spatial sciences. London: Pion.
32. Overeem S., Mignot E., GertvanDijk J., Lammers G.J. Narcolepsy. Clinical features, new pathophysiologic insights, and future perspectives Journal of Clinical Neurophysiology. 18:2001;78-105
33. Perrin J.M., Stein M.T., Amler R.W., Blondis T.A., Feldman H.M., Meyer B.P., et al. Clinical practice guideline. Treatment of the school-aged child with attention-deficit/hyperactivity disorder Pediatrics. 108:2001;1033-1044
34. Pliszka S.R., Browne R.G., Olvera R.L., Wynne S.K. A double-blind, placebo-controlled study of adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 39:2000;619-626
35. Rappley M.D., Gardiner J.C., Jetton J.R., Houang R.T. The use of methylphenidate in Michigan. Archives of Pediatrics and Adolescent Medicine. 149:1995;675-679
36. Rappley M.D., Mullan P.B., Alvarez F.J., Eneli I.U., Wang J., Gardiner J.C. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Archives of Pediatrics & Adolescent Medicine. 153:1999;1039-1045
37. Safer D.J., Zito J.M., Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 98:1996;1084-1088
38. Silver L.B. Controversial approaches to treating learning disabilities and attention deficit disorder. Archives of Disease in Childhood. 140:1986;1045-1052
39. Stano M. Further issues in small area variations analysis. Journal of Health Politics Policy and Law. 16(3):1991;573-588
40. Susser M., Susser E. Choosing a future for epidemiology. II. From black box to Chinese boxes and eco-epidemiology American Journal of Public Health. 86:1996;674-677
41. The MTA Cooperative Group. (1999). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088-1096.
42. US Census Bureau. (1997). Nonemployer statistics health care and social assistance, Michigan. Retrieved June 10, 2003, from Http://www.census.gov/epcd/ nonemployer/1997/mi/MI000_62.HTM
43. Wennberg J., Gittelsohn A. Small area variations in health care delivery. Science. 182(117):1973;1102-1108
44. Wennberg J., Gittelsohn A. Variations in medical care among small areas. Scientific American. 246(4):1982;120-134
45. Wennberg J.E. On patient need, equity, supplier-induced demand, and the need to assess the outcome of common medical practices. Medical Care. 23:1985;512-550
46. Zametkin A.J., Ernst M. Problems in the management of attention-deficit-hyperactivity disorder. New England Journal of Medicine. 340:1999;40-46
47. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association. 283:2000;1025-1030